The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
FRAND compliance and conditional injunctions: key lessons from China’s VoiceAge v. HMD SEP decision
Case background and conditional injunctions A recent ruling by the Fuzhou Intermediate People’s Court has drawn significant attention to China’s evolving approach to standard-essential patent (SEP) disputes. On June 19, 2025, the Court handed down its decision in two...
Clarivate delivers new AI-powered solutions within Innography for competitive benchmarking and standard-essential patent analysis
AI Classifier delivers patent classification with up to 97% first-pass accuracy for portfolio benchmarking, while SEP Analyzer enhances reporting with clear, intuitive visualizations. Clarivate, a leading global provider of transformative intelligence, today announced...
Bike safety and kitchen elegance win big at the DesignEuropa Awards 2025
COPENHAGEN — Today, the design community recognized two exceptional creations and two notable designers in the sixth edition of the DesignEuropa Awards, organized by the European Union Intellectual Property Office (EUIPO) in the Danish capital. The DesignEuropa Awards...
New Minister appointed with responsibility for intellectual property
The UK Intellectual Property Office (UKIPO) CEO has welcomed the new Minister. Kanishka Narayan MP has been confirmed as the new Minister with responsibility for intellectual property following their appointment as Parliamentary Under-Secretary of State in the...
Pharmacyclics LLC v. Deputy Controller of Patents: the evolving landscape of divisional applications in India
The Calcutta High Court's recent judgment in Pharmacyclics LLC v. Deputy Controller of Patents marks a pivotal moment in Indian Patent Law, offering a clear and definitive interpretation of Section 16 of the Indian Patents Act. For years, a persistent ambiguity...
What do patent drafting and Jell-O™ have in common?
If predicting the future were easy, most readers of The Patent Lawyer would be using their powers to buy lottery tickets, not keeping abreast of global patent law updates. Predicting the future, however, is precisely the task attorneys are faced with when drafting a...
Trade secrets and software: secrecy over public right to exclude
As software systems become central to business innovation, trade secret law is crucial for protecting them. The need to protect software and algorithms presents unique challenges for businesses that have long relied on patent protection. The nature of software often...
Delhi High Court holds “algorithms” and “computer program” not patentable
This article discusses an appeal filed by Kroll Information Assurance, LLC (Appellant), against the order of the Controller General of Patents, Designs, and Trademarks (CG). The appeal concerns the refusal of an Indian Patent Application No. 8100/DELNP/2007 for a...
Samsung’s $112M patent verdict: Maxell makes its mark in IP enforcement
In a significant setback for global tech giant Samsung, a Texas federal jury has handed down a USD 111.7 million verdict in favor of Maxell, ruling that Samsung infringed three patents covering user interface technology, multimedia processing, and smart networking....
Optis v. Apple: what the Federal Circuit’s decision means for functional claiming
The Federal Circuit's June 16, 2025, decision in Optis Cellular Technology, LLC v. Apple Inc., 2025 US App. LEXIS 14745 shines a renewed spotlight on a recurring challenge in patent law: functional claiming. Specifically, it reaffirms the court's willingness to apply...
Delhi High Court denies AbbVie’s anti-cMet ADC patent
This article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi High Court against the refusal of their patent application (Application No. 201817047767) for an anti-cMet antibody-drug conjugate by the Assistant...
UPC and EPO diverge on inventive step: lessons from Amgen’s PCSK9 patent battle
In a landmark test of the new Unified Patent Court (UPC), the European patent landscape faces a striking divergence between the UPC and the European Patent Office (EPO) on the issue of inventive step. The dispute centers on Amgen's European patent EP 3 666 797, which...
Therapeutic efficacy is a must for a novel intermediate compound to overcome Section 3(d) objection
In an appeal case between Zeria Pharmaceutical Co. Ltd., v. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) before the Delhi High Court, wherein the appellant - a Japanese Corporation - filed an Indian Patent Application, numbered 3630/DLNP/2011 (the subject...
Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.